What is Onsite Drug Testing?
Onsite Drug Testing of New England is dedicated to providing comprehensive drug and alcohol testing solutions designed to foster substance-free workplaces. Their service portfolio encompasses random testing protocols, specialized training for supervisors and employees, and educational programs customized to meet the specific policies of client businesses. By prioritizing client confidentiality and security, the company aims to bolster workplace safety, enhance employee health, and ultimately drive organizational profitability through effective substance abuse prevention strategies.
How much funding has Onsite Drug Testing raised?
Onsite Drug Testing has raised a total of $76K across 1 funding round:
Debt
$76K
Debt (2021): $76K with participation from PPP
What's next for Onsite Drug Testing?
With the recent influx of substantial expansion capital, Onsite Drug Testing is poised for accelerated growth. This significant Series B/C stage financing is expected to fuel strategic initiatives aimed at broadening service reach and enhancing operational capabilities. The company's focus on creating safer and more productive work environments through robust drug and alcohol testing programs positions it for continued success in a market increasingly prioritizing employee well-being and corporate responsibility.
See full Onsite Drug Testing company page
